Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
아연 피로인산염
아연피로인산염 · 무기아연염류 · 징크 피로포스페이트 · 다이아연 피로포스페이트 · 아연 다이포스페이트 · 아연 다이포스페이트 (Zn2P2O7) · 아연 피로포스페이트 · 아연 피로포스페이트 (Zn2P2O7)
식별자 및 물리적 특성
| CAS No. | 7446-26-6 |
|---|---|
| 분자식 | O7P2Zn2 |
| 평균 분자량 | 304.7 g/mol |
| 단동위원소 질량 | 301.77021 g/mol |
| SMILES | O=P([O-])([O-])OP(=O)([O-])[O-].[Zn+2].[Zn+2] |
| InChIKey | OMSYGYSPFZQFFP-UHFFFAOYSA-J |
| PubChem CID | 62641 |
| EC No. | 231-203-4 |
| DTXSID | DTXSID0064705 |
| 현지명 | 아연 피로인산염 |
화학 및 물리적 성질
| 극성 표면적 | 136 |
|---|---|
| 수소 결합 공여자 수 | 0 |
| 수소 결합 수용자 수 | 7 |
| 회전 가능 결합 수 | 0 |
| 무거운 원자 수 | 11 |
| 형식 전하 | 0 |
| 복잡도 | 124 |
| 물질 분류 | Metals -> Phosphates, Metallic Salts |
| Physical Description | White solid[Merck Index] 30-50% Aqueous solution: Slightly viscous odorless liquid[Klenzoid MSDS] |
| 밀도 | d23 3.75 |
| 용해도 | insoluble in H2Osoluble in dilute acid solutions |
| 물리적 상태 | 백색 결정성 분말 |
| 색상 | white crystals, crystalline powder |
| 용해도 | 물에 불용성, 무기산에 용해됨 [MER06] |
| InChI | InChI=1S/H4O7P2.Zn/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6) |
| InChIKey | MZAGDLUUYJDJTE-UHFFFAOYSA-N |
| SMILES | O(P(O)(O)=O)P(O)(O)=O.[Zn] |
| EPA | Dizinc pyrophosphate (7446-26-6) |
화학적 성질
White powder. Soluble in acids and alkalies; insoluble in water.
안전 및 규제
| GHS 분류 | WarningH400 (95.7%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]P273, P391, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 70 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Not Classified |
|---|---|
| 규제 정보 | Chemical: Diphosphoric acid, zinc salt (1:2)Status: Active Update: 06-12-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/24543Diphosphoric acid, zinc salt (1:2): Does not have an individual approval but may be used under an appropriate group standard |
| 유해성 요약 | An eye irritant[Klenzoid MSDS] See Zinc. See Disodium pyrophosphate. |
| Hazard Classes and Categories | Aquatic Acute 1 (95.7%) |
| 노출 관리 및 개인 보호 | 0.1 [mg/m3] (respirable fraction), 2 mg/m3 (inhalable fraction) for Zn inorg. cmpnds[German Research Foundation (DFG)] |
| Minimum Risk Level | Intermediate Oral: 0.3 mg/kg/day (L134) Chronic Oral: 0.3 mg/kg/day (L134) |
| Treatment | Zinc poisoning is treated symptomatically, often by administering fluids such as water or milk, or with gastric lavage. (L49) |
| 건강 영향 | Chronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. (L49) |
| 노출 경로 | Inhalation (L49)oral (L49)dermal (L49) |
| 독성 요약 | Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49) |
용도
용도
Pigment